Bone marrow-derived mesenchymal stem cells for the treatment of pulmonary emphysema
The aim of this study is to show safety and feasibility of autologous bone marrow-derived mesenchymal stem cell (MSC) therapy for patients with emphysematous lung tissue.
Read More
Product Information for
Bone marrow-derived mesenchymal stem cells for the treatment of pulmonary emphysema